PP201 – Intrathecal Targeted Drug Delivery: Collaboratively Enhancing the Continuum of Care
Intrathecal Targeted Drug Delivery: Collaboratively Enhancing the Continuum of Care.
Natalie DeGroff MS, RN, FNP-C, Pamela Carter RN, MBA, Koshy Mathew PharmD, MBA, DAAPM, BCMAS, Jonathan Hamer PharmD, MBA, BCPS
Continuous intrathecal drug delivery is a life-changing treatment for patients experiencing chronic pain, spasticity, and its underlying illnesses. The focus of this specialized care coordination program is to maximize outcomes and value in patient-centered care. Program objections aim to bridge the gap in intrathecal therapy management through proactive patient engagement, support services, cost savings, and maintaining the continuum of care within patient’s healthcare team.
Patients with intrathecal implanted pumps are offered proactive telephonic nursing assessments and interventions, pharmacy consultation and treatment optimization, and reimbursement support services. The initial pilot program led to further market research which revealed this is a relatively new concept within the practice of intrathecal therapy management and yielded a strong level of interest for the program’s successful implementation.
Review of six months of pilot program outcomes data trends demonstrates optimization of patient outcomes based on nursing and pharmacy interventions. The care coordination program provides timely, efficient, safe, and patient-centered care through collaborative management and patient engagement.
Throughout the development of the care coordination program, it has been confirmed the service is a value-added program that is making a meaningful impact on patient care and outcomes. As the scale of the care coordination program grows, incorporation of continued learnings through market research, outcomes analysis, patient and provider satisfaction results, and strengthening the partnership within the healthcare team will be critical to the long-term success of the program.
1. Incorporation of continued learnings through market research to ensure the long-term success of the program
2. Analysis of outcomes, patient, and provider satisfaction results to demonstrate the benefits of the value-added program
3. Strengthening the partnership within the healthcare team